S2C3：Clinical Trials of Drug Products

原文始发于微信公众号（化学音乐文化）：S2C3：Clinical Trials of Drug Products

JanFourman,PhD, EdD,MBA, MSRA

S2C3：Clinical Trials of Drug Products

Eli Lilly – Pharma registration for diabetes/endocrine, women/men’s health, neural science, oncology, bone/muscle/joint therapeutic areas – 5 years

Eli Lilly – Pharmacovigilance – 7 years

Eli Lilly – Regulatory Intelligence – 3 Years

Purdue University and Roche Diagnostics – Teaching global pharma development, Africa and US

Consultant for Indiana Technical Assistance Program

Invited conference speaker

Published author

扫描左侧二维码，获取视频课；扫描右侧二维码，获取音频课

Clinical Trials of Drug Products

Initial Processing of the IND

Clinical Hold

If it’s a go – are you up-to-date with the clinical trial trends?

Phase 1

Exploratory Studies

Phase 2

End-of-Phase 2 (EOP2) Meetings

Phase 3

ClinicalTrials.gov

Phase 4

Pharmacovigilance

发布者：药时代，转载请首先联系contact@drugtimes.cn获得授权